Van der Boechorststraat 7
Afdeling MMI Kamer B-340
1081 BT Amsterdam
The Netherlands
T +31 20 444 8307
info@microbiome.nl
Nederlands English

About us

Microbiome is leading in the field of innovative molecular microbiological diagnostics. read more >

Diseases

Finding innovative solutions to medical problems drives us. read more >

Improving healthcare through innovation

Microbiome is active in the discovery, development, manufacturing and marketing of innovative molecular microbiological techniques, tools, systems,
kits and characterizations.


Targets: Mycobacterium Tuberculosis complex
Unique test that can detect Chlamydia trachomatis and N. gonorrhoeae in all their variants
Highly sensitive detection of HPV DNA (broad range of genotypes)
Tuberculosis, MTB or TB (short for tubercle bacillus) is a common and in many cases lethal infectious disease caused by various strains of mycobacteria, usually Mycobacterium tuberculosis.
illustratie
Chlamydia is a genus of bacteria that are obligate intracellular parasites.
illustratie
Gonorrhea (also colloquially known as the clap) is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae.
illustratie


Latest news

As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate,... read more >

Growing Resistance to Gonorrhea Treatment

Recent research explains why treating gonorrhea has grown more difficult. Scientists from Harvard University, the Centers for Disease Control and Prevention... read more >

Partners of Microbiome

We develop integrated solutions together with leading manufacturers from the diagnostics and pharmaceutical industries, helping them to leverage our leading sample & assay technologies as part of their own offerings. read more >